NCT07757282 Peripheral Blood Lipidomic and Ceramide Profiles in Atrial Fibrillation
| NCT ID | NCT07757282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2017-06-15 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2017-06-15 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective multi-cohort observational study evaluates the association between peripheral blood lipidomic and ceramide profiles and atrial fibrillation. The study hypothesis is that peripheral blood lipidomic features and ceramide-related profiles are associated with the presence of atrial fibrillation. Participants with atrial fibrillation and control participants with other cardiovascular diseases will be prospectively enrolled. Peripheral blood samples will be analyzed using untargeted lipidomic profiling in one cohort and targeted ceramide assays in another cohort.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older. * Participants who are able to provide informed consent. * Participants diagnosed with atrial fibrillation based on Holter monitoring, or control participants with other cardiovascular diseases and no documented atrial fibrillation. * Participants with available peripheral blood samples for untargeted lipidomic profiling or targeted ceramide analysis. Exclusion Criteria: * Inability or unwillingness to provide informed consent. * Missing key clinical information. * Missing or poor-quality peripheral blood samples unsuitable for lipidomic or targeted ceramide analysis. * Participants considered unsuitable for this study by the investigators.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07757282 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07757282 currently recruiting?
Yes, NCT07757282 is actively recruiting participants. Contact the research team at zwhy19324@gmail.com for enrollment information.
Where is the NCT07757282 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT07757282 clinical trial?
NCT07757282 is sponsored by First Affiliated Hospital Xi'an Jiaotong University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.